Trial site
Centrum Medyczne Plejady
Krakow, 30-363, PolandEU-13 widening countryNot linked to an institution yet
- 9running trials
- 15closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Phase
- Phase 312 trials
- Phase 211 trials
- Phase 1/21 trial
- Status
- Completed12 trials
- Recruiting5 trials
- Active, not recruiting3 trials
- Terminated3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Takeda4 trials
- SK Life Science, Inc.3 trials
- Janssen Research & Development, LLC2 trials
- Abivax S.A.1 trial
- Boehringer Ingelheim1 trial
- and 13 more
Running trials
Recruiting
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
NCT07580716· Phase 2· Enlivex Therapeutics Ltd.· Source
Contact: Alicja Włoch, MD
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
NCT06798896· Phase 2· Supernus Pharmaceuticals, Inc.· Source
Contact: Supernus Clinical Trials
Recruiting
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
NCT06636656· Phase 2· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Active, not recruiting
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
NCT06559163· Phase 2· Zenas BioPharma (USA), LLC· Source
Active, not recruiting
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
NCT06392009· Phase 1/2· GRIN Therapeutics, Inc.· Source
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
NCT05897320· Phase 3· H. Lundbeck A/S· Source
Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
NCT05219617· Phase 3· SK Life Science, Inc.· Source
Contact: Marta Zolnowska, MD (principal investigator)
Active, not recruiting
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
NCT05177835· Phase 2· Abivax S.A.· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
NCT05668390· Phase 3· Stallergenes Greer· Source
Completed
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
NCT05368285· Phase 2· Celldex Therapeutics· Source
Terminated
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome
NCT05163314· Phase 3· Takeda· Source
Completed
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
NCT05067634· Phase 3· SK Life Science, Inc.· Source
Completed
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
NCT05192200· Phase 2· Pfizer· Source
Completed
A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)
NCT05122650· Phase 2· Jazz Pharmaceuticals· Source
Terminated
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
NCT04985968· Phase 3· InDex Pharmaceuticals· Source
Completed
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
NCT04938427· Phase 3· Takeda· Source
Completed
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome
NCT04940624· Phase 3· Takeda· Source
Completed
Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis
NCT05087030· Phase 3· Gedeon Richter Plc.· Source
Completed
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
NCT04882878· Phase 2· Janssen Research & Development, LLC· Source
Completed
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
NCT04440592· Phase 2· Tanabe Pharma America, Inc.· Source
Completed
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
NCT04205812· Phase 3· Incyte Corporation· Source
Completed
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
NCT03678753· Phase 3· SK Life Science, Inc.· Source
Terminated
A Study of Soticlestat in Adults and Children With Rare Epilepsies
NCT03635073· Phase 2· Takeda· Source
Report an error